Patent Assignment
Reel/Frame 072148/0362
Assignment of Assignor's Interest
Recorded: 2025-09-03
Pages: 3
Assignor
LIN, WU
Executed: 2016-07-28
Assignee
QUOTIENT CLINICAL LIMITED
TRENT HOUSE, MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, RUDDINGTON, NG11 6JS, UNITED KINGDOM
Covered Property
(1)
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-yl]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-yl)Piperazin-1-yl]Pent-2-Enenitrile
Application:
19/217,161 →
Publication:
US 2025/0381193
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 3, 2025
From: QUOTIENT CLINICAL LIMITED
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072148/0365 →
Assignment of Assignor's Interest
Sep 3, 2025
From: MASJEDIZADEH, MOHAMMAD; FERDOUS, ABU
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072148/0420 →
Assignee Change of Address
Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →